Lansky AJ, Makkar R, Nazif T, Messe S, et al. A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial. Eur Heart J 2021 May 17. pii: 6277114. doi: 10.1093.
PMID: 34000004